Why Soleno Therapeutics Stock Blasted 9% Higher Today

Source The Motley Fool

Soleno Therapeutics (NASDAQ: SLNO) had some good news to report on the regulatory front on Tuesday. Investors were cheered by this as evidenced by their sending the biotech's stock more than 9% higher in price on the day. This performance was much better than that of the closely watched S&P 500 index, which closed up by less than 1%.

Skipping ahead in the review process?

Before market open that day, Soleno reported that the U.S. Food and Drug Administration's (FDA) review division determined there was no need for an advisory committee meeting on a crucial submission from the company, at least for now. This is a new drug application (NDA) for the company's diazoxide choline (DCCR) tablets aimed at the treatment of genetic disorder Prader-Willi Syndrome.

Soleno isn't entirely in the clear to skip this typical step in the NDA process; the regulator added that it would continue to consider the need for such a meeting while it reviews the application.

Either way, the FDA seems headed for a decision on DCCR in the very near future. The drug has been designated as a priority review by the healthcare-industry regulator, with a target-action date of this coming Dec. 27.

No guarantees, but...

These are not the only factors in DCCR's favor; in late April, the FDA granted the drug its breakthrough-therapy designation, a tag that also tends to hasten the approval process. While an FDA nod is never guaranteed for any medication, no matter how solid its performance in the lab, the prospects for Soleno's leading program look excellent at the moment.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

  • Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $20,363!*
  • Apple: if you invested $1,000 when we doubled down in 2008, you’d have $41,938!*
  • Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $378,539!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of October 7, 2024

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Nvidia Q3 Earnings Loom as Market Expects Revenue Near $109 Billion: Can NVDA Stock Hold $150? As of the close on November 16 ET, Nvidia (NVDA) shares fell 4.12% to close at $156.14, with an intraday low of $155.01 and trading volume of about 334 million shares. Compared with its p
Author  TradingKey
7 hours ago
As of the close on November 16 ET, Nvidia (NVDA) shares fell 4.12% to close at $156.14, with an intraday low of $155.01 and trading volume of about 334 million shares. Compared with its p
placeholder
Gold Price Forecast: Gold Holds Key $3,850 Support, US October Retail Sales May Drive Rebound Toward $4,000As of the Asian session on Tuesday (November 17), gold (XAUUSD) maintained a weak rebound intraday today after recent continuous declines to a nearly one-year low, edging up 0.2% during t
Author  TradingKey
7 hours ago
As of the Asian session on Tuesday (November 17), gold (XAUUSD) maintained a weak rebound intraday today after recent continuous declines to a nearly one-year low, edging up 0.2% during t
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 17, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
Author  Mitrade
11 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
placeholder
Australian Dollar declines below 0.6750 after RBA minutes, US Retail Sales data in focusThe AUD/USD pair trades with mild losses around 0.6730 during the early Asian session on Tuesday.
Author  FXStreet
15 hours ago
The AUD/USD pair trades with mild losses around 0.6730 during the early Asian session on Tuesday.
placeholder
Bitcoin Plunges 13% in a Week as Market Retreats to $60,000 LevelBitcoin plunged 13% over the past seven days as bullish defense lines crumbled in succession, officially kicking off the battle to defend the $60,000 mark.On November 16, following a viol
Author  TradingKey
Yesterday 10: 05
Bitcoin plunged 13% over the past seven days as bullish defense lines crumbled in succession, officially kicking off the battle to defend the $60,000 mark.On November 16, following a viol
goTop
quote